From DCAT Value Chain Insights (VCI)
Takeda Pharmaceuticals has appointed Ricardo Marek as the president of the Emerging Markets Business Unit (EM BU) in Singapore, effective as of April 1, 2017. In his new role, Mr. Marek will lead all business operations across five geographic areas that comprise EM BU: Asia Pacific (excluding Japan), China, Latin America, Middle East & Africa, and Russia-CIS (Commonwealth of Independent States). Mr. Marek will also serve as a corporate officer and member of Takeda’s executive team and will report to Christophe Weber, president and chief executive officer of Takeda.
After joining Takeda in 2011, Mr. Marek became president of Takeda Brazil in 2013. He then took on additional, concurrent responsibilities as area head of Latin America in 2014. Mr. Marek succeeds Giles Platford who has moved to Zurich as president of Europe and Canada, also effective April 1, 2017.
Mr. Marek’s experience also includes completing strategic acquisitions for Takeda across Latin America as well as launching the oncology business in that part of the world.
Source: Takeda Pharmaceuticals
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription